Pinnacle Investment Management Ltd Takes Position in Tempus AI, Inc. $TEM

Pinnacle Investment Management Ltd bought a new stake in shares of Tempus AI, Inc. (NASDAQ:TEMFree Report) during the second quarter, HoldingsChannel.com reports. The fund bought 1,200 shares of the company’s stock, valued at approximately $76,000. Tempus AI makes up about 0.4% of Pinnacle Investment Management Ltd’s holdings, making the stock its 13th largest holding.

Other hedge funds have also recently modified their holdings of the company. Pathway Capital Management LP bought a new position in shares of Tempus AI during the first quarter valued at approximately $8,576,000. SeaCrest Wealth Management LLC bought a new position in shares of Tempus AI during the first quarter valued at approximately $535,000. Sumitomo Mitsui Trust Group Inc. grew its stake in shares of Tempus AI by 31.4% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock valued at $205,284,000 after buying an additional 1,016,384 shares during the last quarter. Massachusetts Financial Services Co. MA grew its stake in shares of Tempus AI by 92.6% during the first quarter. Massachusetts Financial Services Co. MA now owns 578,890 shares of the company’s stock valued at $27,926,000 after buying an additional 278,311 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. bought a new position in Tempus AI in the first quarter worth approximately $1,019,000. Institutional investors own 24.22% of the company’s stock.

Insider Transactions at Tempus AI

In related news, EVP Erik Phelps sold 3,664 shares of Tempus AI stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $273,517.60. Following the completion of the sale, the executive vice president owned 94,115 shares in the company, valued at approximately $7,025,684.75. This trade represents a 3.75% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the business’s stock in a transaction on Thursday, September 25th. The stock was sold at an average price of $76.56, for a total transaction of $25,456,200.00. Following the completion of the transaction, the chief executive officer owned 9,141,032 shares of the company’s stock, valued at approximately $699,837,409.92. This trade represents a 3.51% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 933,662 shares of company stock worth $67,909,393 in the last three months. Company insiders own 26.27% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. Bank of America increased their price objective on Tempus AI from $68.00 to $70.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 25th. Morgan Stanley increased their target price on Tempus AI from $65.00 to $68.00 and gave the company an “overweight” rating in a research report on Tuesday, August 12th. HC Wainwright increased their target price on Tempus AI from $90.00 to $98.00 and gave the company a “buy” rating in a research report on Friday, September 12th. Guggenheim increased their target price on Tempus AI from $80.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 26th. Finally, Piper Sandler reaffirmed a “neutral” rating on shares of Tempus AI in a research report on Friday, August 8th. Seven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Tempus AI presently has a consensus rating of “Moderate Buy” and a consensus target price of $71.83.

View Our Latest Stock Report on Tempus AI

Tempus AI Trading Up 9.0%

TEM stock opened at $87.99 on Thursday. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. Tempus AI, Inc. has a 12-month low of $31.36 and a 12-month high of $97.79. The stock has a market cap of $15.29 billion, a price-to-earnings ratio of -73.94 and a beta of 4.89. The business’s 50-day moving average is $73.92 and its 200 day moving average is $62.59.

Tempus AI (NASDAQ:TEMGet Free Report) last released its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. The business had revenue of $314.64 million for the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The business’s revenue was up 89.5% on a year-over-year basis. During the same period last year, the company posted ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. On average, sell-side analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

About Tempus AI

(Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

See Also

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEMFree Report).

Institutional Ownership by Quarter for Tempus AI (NASDAQ:TEM)

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.